​Cindy Eckert built and sold Sprout Pharmaceuticals in one of the most controversial and highly scrutinized categories in healthcare. Her experience navigating the FDA, public controversy, investor skepticism, and media narratives offers a masterclass for founders building in fintech, healthtech, climate, AI, or any regulated vertical.

​Speaker

​Cindy Eckert

​Cindy Eckert, CEO and Founder of Sprout Pharmaceuticals, made history by bringing Addyi — the first and only FDA-approved drug for hypoactive sexual desire disorder (HSDD) in women, also known as low libido — to market. In 2015, Eckert sold Sprout Pharmaceuticals for a record-breaking $1 billion. She later fought to reacquire the company and reclaim control of Addyi to continue her mission of breaking down barriers in women’s sexual health and fighting for gender equity in healthcare.

As a celebrated entrepreneur and fierce advocate for women’s sexual health with over 25 years of experience in sexual wellness and pharmaceuticals, Eckert’s impact extends beyond pharmaceuticals - she is known for her bold approach to business, commitment to fighting gender bias in medicine, and her fierce advocacy for women’s health innovation. Eckert, who has made “the little pink pill” a personal lifestyle, has no plans to stop challenging inequities in healthcare.

Addyi celebrated the 10 year anniversary of its FDA approval for the treatment of premenopausal women in August 2025 and closed out 2025 with another historic first in women’s sexual health. As of December 2025, Addyi is also FDA approved for the treatment of postmenopausal women.

​Location

​Raleigh Founded North Street

​509 W North St Suite 224, Raleigh, NC 27603

​Questions?

​This session is part of Raleigh-Durham Startup Week. Click here to learn more about the event, plus get answers to your FAQs.

​TRACK SUPPORTER

​​Thank you to Smith Anderson for supporting the Keynotes Track at #RDSW26!